Kent-based Bedfont Scientific, has launched UK production of its iCO™ Smokerlyzer® to be shipped worldwide.

Bedfont Scientific Ltd, based in Kent, has been in the business of breath analysis and gas monitoring for almost 40 years now. Their name is well known throughout the medical industry thanks to their high quality breath analysers. They have several products including the Gastrolyzer range, which offers a non-invasive method to diagnose food intolerances and gastrointestinal disorders; the NObreath FENO monitor, which aids in the management & treatment of respiratory diseases, helping to differentiate between respiratory conditions such as asthma and COPD; and the Smokerlyzer range, a carbon monoxide (CO) monitor that is a motivational tool for smoking cessation. Most recently, Bedfont Scientific has launched the iCO™ Smokerlyzer®, the world’s first Smokerlyzer CO monitor for your smartphone or tablet.

Jason Smith, Bedfont’s General Manager, comments,

“We have traditionally manufactured our high volume products in China and thanks to the Manufacturing Advisory Service, this is the first of the range to be built here in Kent.  The iCO Smokerlyzer is proudly designed, manufactured, assembled, packaged and distributed here in Kent. This will undoubtedly provide greater control over quality and supply; bringing benefits to both companies. Bedfont had a forty percent increase in sales turnover in the past two years with seventy-eight percent of turnover being generated from exports. We predict that a homecare breath CO monitor will greatly increase exports, especially since our main target is the USA, which has huge demand for consumer healthcare devices.”

The product launch and UK production is expected to further boost exports to the company’s worldwide range of clients. Bedfont Scientific is a National Champion for Exporting, and an Export Category nominee in the European Business Awards.

Bedfont Scientific, based in Kent, a leading manufacturer of breath testing equipment in the UK releases the latest CO monitor for use with smartphones and tablets, to help people stop smoking.

Quitting smoking has never been easy, but it is a habit that more and more  people are trying to give up, especially with more laws than ever before banning smoking in public places and now in the UK from October 2015 in cars.

Bedfont Scientific Ltd, a pioneer in smoking cessation monitors, has combined the drive to quit smoking with the ever-growing use of technology and applications to create the latest CO monitor that connects to your smartphone or tablet. Bedfont has produced the Smokerlyzer® for 30  years which offers an easy to use hand-held and non-invasive way to test the level of Carbon Monoxide (CO) in a patient’s blood. They recognise that mobile phones and tablets play a significant part in consumers’ lives and wanted to adapt the technology so that CO monitoring could be more accessible to those who do not have the time to consult a specialist, and so iCO was born.

Due to be launched November 2015, the iCO Smokerlyzer is small, sleek and portable. Once you have the app, the monitor is easy to use and instant readings can be downloaded to your personal profile, meaning you can track your progress, and be motivated, anytime, anywhere. Using a monitor to assist with quitting is proven to improve end results.

A study by  Beard and West (2012) on the effectiveness of personal carbon monoxide monitoring, found that out of ten smokers, “seven of the smokers reported that they felt as though the monitors had reduced their cigarette consumption… Six smokers reported a lower nicotine dependency relative to baseline. Over the six weeks there appeared to be a significant decline in the number of cigarettes smoked per day”.

Beard, E. and West, R. (2012). Pilot Study of the Use of Personal Carbon Monoxide Monitoring to Achieve Radical Smoking Reduction. J. Smok Cessat, 7(01), pp.12-17. (Accessed: 19th October 2015).

The iCO offers consumers the opportunity to save money, and take control of their quitting progress, one breath at a time.